All In MedTech

FDA Clearance Tracker · P910023-S254

CADENCE FAMILY OF ICDS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 4, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 4, 2011

Approved

Time to decision

132 days

Received Nov 23, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P910023-S254
Device name
CADENCE FAMILY OF ICDS
Applicant location
Sylmar, CA
Received
Nov 23, 2010
Decided
Apr 4, 2011
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P910023

Device type

Device class
Class III

Every decision under product code NVZ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODEL 3330 VERSION 12.1 SOFTWARE FOR THE MODEL 3650 MERLIN PATIENT CARE SYSTEM.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.